MMP13 and B-cell chronic lymphocytic leukemia: It has been proven that miRNA has direct or indirect effects on osteosarcoma, such as targeting matrix metalloproteinase 13 (MMP13) and B cell CLL/lymphoma 2 (Bcl-2).